Atea Pharmaceuticals, Inc.

AVIR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001593899

SEC filings (opens in a new tab)

No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Atea Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022 All holders in Q3 2022

13F holders of AVIR: Q3 2022 compared with Q4 2022
Measure	Q3 2022	Of which not filed for Q4 2022	Q4 2022	Change
Holders	126	1	131	+6
Shares	57.4M	39	57.8M	+386.4K (+0.7%)
Value	$326.8M	$0	$278.1M	−$48.7M (−14.9%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to AVIR in Q4 2022
Institution	Shares	Value	% of portfolio
Tyrus Capital S.A.M.	1,260,000	$6.06M	13.20%
Sectoral Asset Management Inc	281,403	$1.35M	0.26%
Vontobel Holding Ltd.	281,403	$1.35M	0.01%
RBF Capital, LLC	268,191	$1.29M	0.10%
Norges Bank	204,200	$982.2K	0.00%
Millennium Management LLC	179,686	$864.0K	0.00%
HRT Financial LP	133,597	$642.0K	0.01%
Jump Financial, LLC	60,400	$290.5K	0.02%
Gsa Capital Partners LLP	56,920	$274.0K	0.03%
Alps Advisors Inc	56,612	$272.3K	0.00%
Ergoteles LLC	56,031	$269.5K	0.01%
Cubist Systematic Strategies, LLC	41,124	$197.8K	0.00%
Squarepoint Ops LLC	39,014	$187.7K	0.00%
State of Wyoming	31,906	$153.5K	0.05%
Alpine Global Management, LLC	10,858	$52.0K	0.02%
Blair William & Co	10,458	$50.3K	0.00%
Aquatic Capital Management LLC	7,700	$37.0K	0.00%
Point72 Middle East FZE	2,287	$11.0K	0.00%
South State Corp.	565	$2.72K	0.00%
Farther Finance Advisors, LLC	296	$1.42K	0.00%
Nisa Investment Advisors, LLC	120	$1.00K	0.00%
Advisory Services Network, LLC	200	$962	0.00%
Romano Brothers and Company	48	$231	0.00%
Colonial Trust Advisors	46	$221	0.00%
NewSquare Capital LLC	8	$38	0.00%

Sold out (19)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of AVIR in Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
K2 Principal Fund, L.P.	605,419	$3.44M
Graham Capital Management, L.P.	149,973	$853.0K
Two Sigma Investments, LP	98,482	$560.0K
Massachusetts Financial Services Co	51,137	$291.0K
Victory Capital Management Inc	42,666	$243.0K
Virtu Financial LLC	30,693	$175.0K
Teacher Retirement System of Texas	15,557	$89.0K
Gotham Asset Management, LLC	11,431	$65.0K
ExodusPoint Capital Management, LP	11,293	$64.0K
The PNC Financial Services Group, Inc.	5,000	$28.0K
Estate Counselors, LLC	1,000	$5.00K
Signaturefd, LLC	390	$2.00K
O'Dell Group, LLC	200	$1.00K
Tyler-Stone Wealth Management	154	$1.00K
CWM, LLC	24	$0
Capital Advisors, Ltd. LLC	22	$0
Ellevest, Inc.	13	$0
Quadrant Capital Group LLC	87	$0
Dark Forest Capital Management LP	31	$0

Not filed for Q4 2022 yet (1)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVIR in Q3 2022 that haven't filed for Q4 2022
Institution	Shares, Q3 2022	Value, Q3 2022
Wipfli Financial Advisors LLC,	39	$0